BRUDYITIS
INGREDIENTS:
Omega-3 fatty acids concentrated fish oil (Tridocosahexanoína-AOX® as source of Docosahexaenoic acid); capsule: Gelatin; stabiliser: Glycerol; thickener: Yellow bee wax; stabiliser: Sorbitol syrup; emulsifier: Lecithins (from sunflower); Zinc Oxide, Dicalcium Phosphate, L-selenomethionine; L-Glutathione; Manganese sulphate; Colour: Iron Oxides and Hydroxides; stabiliser: Silicon Dioxide; Cupric sulphate. Gluten and dairy free.
BRUDYITIS® has been conceived to supplement daily requirements in essential fatty acids of the Omega-3 family and of the included group of minerals and Glutathione. Brudy has developed and patented a unique source of docosahexaenoic acid (DHA), different from other DHA products on the market: Tridocosahexanoína-AOX®. Docosahexaenoic acid (DHA) contributes to the maintenance of normal brain function and normal vision. The beneficial effect is obtained with a daily intake of 250 mg DHA. Eicosapentaenoic acid (EPA) and DHA contribute to the normal function of the heart. The beneficial effect is obtained with a daily intake of 250 mg EPA and DHA. Zinc contributes to the maintenance of normal vision. Zinc, copper and selenium contribute to the normal function of the immune system and together with manganese contribute to the protection of cells from oxidative stress.
INSTRUCTIONS FOR USE:
It is recommended a daily dose of 1 to 2 capsules per day, accompanied by a glass of water at meal times.
WARNINGS: Food supplements should not be used as a substitute for a balanced and varied diet. Do not exceed the stated
recommended daily dose. Not recommended in case of hypersensitivity or allergy to any of the formulation constituents. In case of pregnancy and breastfeeding, check with your doctor before taking this product.
KEEP OUT OF THE REACH OF YOUNG CHILDREN.
STORAGE:
Best if consumed before the end of the month printed on the container. Keep away from light and heat. Store in a dry place in its original packaging and temperature below 25 º C.
Text revised in May 2026 (effective as of the next batch).

